Ayurvedic and allopathic management along with diet and yoga in dyslipidemia

Efficacy of Integrated Ayurveda Protocol in Dyslipidemia A randomized controlled clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063163

Enrollment

Registered

2024-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed subjects of Dyslipidemia not on any medications Subjects with Dyslipidemia (Total Cholesterol to HDL Ratio greater than or equal to 5 ) Patient with age group between 18 to 70

Exclusion criteria

Exclusion criteria: Patient who are diagnosed to have systemic disorders like diagnosed with Diabetes mellitus Uncontrolled Hypertension Systolic more than 140mmhg and Diastolic more than 90mmhg and any serious systemic illness Pregnant and Lactating women Drug induced Dyslipidemia Patient who are having a past history of Stroke MI Severe Pulmonary dysfunctions which interfere with the treatment

Design outcomes

Primary

Measure	Time frame
Primary outcome will be based on Total cholesterol HDL ratioTimepoint: Baseline 90th days	—

Secondary

Measure	Time frame
Secondary outcome will be based on Small dense LDL particles size Insulin resistance parameter (TG to HDL-C ratio) Very low density lipoprotein and Serum triglyceride levels Anthropometry and QoL- SF36Timepoint: Small dense LDL particles size Insulin resistance parameter (TG to HDL-C ratio) Very low density lipoprotein and Serum triglyceride levels (baseline and 90th day) Anthropometry and QoL- SF36 (baseline 30th 60th and 90th day)	—

Measure

Time frame

Secondary outcome will be based on Small dense LDL particles size Insulin resistance parameter (TG to HDL-C ratio) Very low density lipoprotein and Serum triglyceride levels Anthropometry and QoL- SF36Timepoint: Small dense LDL particles size Insulin resistance parameter (TG to HDL-C ratio) Very low density lipoprotein and Serum triglyceride levels (baseline and 90th day) Anthropometry and QoL- SF36 (baseline 30th 60th and 90th day)

—

Countries

India

Contacts

Public ContactDR SUKETHA KUMARI

KAHERs SHRI BMK AYURVEDA MAHAVIDYALYA SHAHPUR, BELAGAVI, KARNATAKA

sukethashetty411@gmail.com9483637757

Outcome results